
Saudi Arabia Self Monitoring Blood Glucose Market Overview
Market Size in 2024: USD 88.53 Million
Market Forecast in 2033: USD 212.18 Million
Market Growth Rate 2025-2033: 9.30%
According to IMARC Group's latest research publication, "Saudi Arabia Self Monitoring Blood Glucose Market Size, Share, Trends and Forecast by Component and Region, 2025-2033", the Saudi Arabia self monitoring blood glucose market size reached USD 88.53 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 212.18 Million by 2033, exhibiting a growth rate (CAGR) of 9.30% during 2025-2033.
Download a sample PDF of this report: https://www.imarcgroup.com/saudi-arabia-self-monitoring-blood-glucose-market/requestsample
How Digital Technology Reshaping the Future of Saudi Arabia Self Monitoring Blood Glucose Market
Saudi Arabia Self Monitoring Blood Glucose Market Trends & Drivers:
The Saudi Arabia self-monitoring blood glucose market is growing significantly due to the high prevalence of diabetes, which affects millions across the Kingdom. Diabetes rates are driven by lifestyle factors such as obesity and sedentary habits, making glucose monitoring essential for disease management. The shift towards Continuous Glucose Monitoring (CGM) systems is notable, as these devices offer real-time tracking through wearable sensors and smartphone apps. The convenience and comfort of CGM devices, coupled with their ability to transmit data to healthcare providers for personalized treatment, have made home care the dominant segment, accounting for over 80% of market value.
Technological innovation is another major factor powering growth. Advances in non-invasive glucose monitors and integration of glycemic devices with AI-powered insulin pens and automated delivery systems enhance patient experience and accuracy. For example, partnerships like Abbott and Medtronic bring combined CGM and insulin pumps to Saudi patients, allowing better glucose control and reducing hypoglycemia risks. Smartphone-enabled devices with Bluetooth connectivity enable patients to easily share data with clinicians remotely, improving ongoing diabetes management and proactive intervention efforts in line with Saudi Arabia’s digital health agenda.
Government initiatives and public health campaigns are also catalyzing market expansion. Saudi Arabia’s Vision 2030 healthcare reforms focus heavily on early diabetes screening, awareness, and prevention, supported by mobile clinics and school programs. Subsidies and insurance coverage increase access to SMBG devices. Significantly, the launch of the world’s first digital diabetes command center exemplifies the Kingdom’s leadership in healthcare innovation, enabling real-time digital monitoring of diabetic patients nationwide. This facility enhances proactive care and supports patients in managing their conditions effectively, marking a milestone in patient-centered and preventive diabetes care.
Saudi Arabia Self Monitoring Blood Glucose Industry Segmentation:
The report has segmented the market into the following categories:
Component Insights:
Regional Analysis:
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Recent News and Developments in Saudi Arabia Self Monitoring Blood Glucose Market
Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-201971-6302
